SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing increased volatility and negative sentiment driven by concerns over launch delays, the lack of status updates regarding the BlueBird 11 satellite, and broader macroeconomic pressures. While some retail investors remain committed to the long-term thesis and continue to accumulate shares, others are expressing frustration with management's communication and reacting to class-action litigation news.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines shares are moving in response to the company's successful completion of in-orbit commissioning and delivery of the SXM-11 satellite to SiriusXM. While the company's recent operational milestones are noted, the conversation is largely dominated by intense retail sentiment debates, arguments regarding sector-wide volatility, and skepticism about the stock's performance relative to broader market trends.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

The recent failure of the CLARITY Act to advance in the Senate has triggered a sharp sell-off in crypto-related equities, with traders expressing disappointment and frustration over the stalled regulatory progress. Market participants remain deeply divided, with some bearish traders predicting further downside and others viewing the volatility as a potential buying opportunity for the long term.

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Wingstop is facing significant selling pressure amid a broader market decline in restaurant stocks, driven by reports of reduced consumer dining traffic and persistent inflation concerns. Traders are debating whether the sharp selloff represents a generational buying opportunity or indicates a deeper fundamental failure, with many expressing frustration over the persistent downtrend.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is experiencing significant volatility and a price decline following the Senate's failure to advance the Crypto Clarity Act. While some traders view the legislative setback as a bearish signal, others remain optimistic, arguing that institutional adoption continues and that regulatory progress will now shift to federal agencies.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer shares dropped significantly following the expiration of its post-IPO insider lock-up period, which unlocked a large portion of the company's share supply and triggered selling pressure from early investors looking to realize gains. While some traders are treating the decline as a buying opportunity, others remain cautious, citing concerns over future share dilution and a lack of substantial revenue.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending primarily due to positive Phase 3 clinical data for plozasiran in treating severe hypertriglyceridemia, which triggered a significant stock rally and multiple analyst price target increases. While some traders debate the stock's market-driven price volatility and the broader implications of its RNAi platform, the consensus reaction remains bullish regarding the company's long-term commercial prospects and potential as an acquisition candidate.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending due to record-setting fiscal fourth-quarter results and fiscal 2027 guidance that exceeded expectations, driven by strong demand for power infrastructure. Traders are closely monitoring the company's record $3 billion backlog and expansion plans, despite some ongoing volatility and debates regarding historical price patterns.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending as part of a broad sell-off across the restaurant sector, driven by data indicating a decline in brick-and-mortar dining traffic. While some traders view the pullback as an oversold buying opportunity due to the company's growth profile, others argue the valuation remains excessive given the cooling consumer environment.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

Investors are expressing significant frustration over QXO's persistent downward price action, which many attribute to a combination of high interest rates, macroeconomic volatility, and the company's aggressive M&A strategy. While some traders are liquidating positions due to pessimism regarding the housing market and interest rate environment, others remain focused on the long-term potential of CEO Brad Jacobs' consolidation thesis and are using the current weakness to accumulate shares.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

H.C. Wainwright reiterated $CNTB Buy-$7 and said -- We recently hosted a KOL discussion ahead of Connect Biopharma&#39;s upcoming Seabreeze STAT asthma and COPD readouts and came away incrementally more positive on the setup. 
$SNY - REGN VRNA GSK AZN ABBV INSM LQDA 
H.C. Wainwright added—Most importantly, the KOL viewed treatment failure, including recurrent exacerbations and repeat acute-care utilization, as the most clinically meaningful measure of success, with approximately 30% relative reduction representing a meaningful win, ~40% a strong outcome and ~50% an especially compelling result. 
 
FEV1 remains important, but in our view the discussion reinforces that Seabreeze should be assessed primarily on whether rademikibart meaningfully reduces treatment failure over 28 days as that is the key measure physicians care about in practice. 
 
We believe this provides a favorable framework heading into the catalyst and remain positive on CNTB shares.

David Stockney

John

Oppenheimer🏁 $CNTB and said -- We are initiating coverage of Connect Biopharma (CNTB) with an Outperform rating and an $8 PT. 
$SNY - $REGN INSM VRNA INSM AZN GSK NVS AMGN UPB 
Oppenheimer added—Connect is developing rademikibart for inflammatory respiratory diseases. 
 
A single-asset story, CNTB is built on rademikibart (formerly CBP-201), a next-generation human IgG4 anti-IL-4Ra antibody that binds with higher affinity than dupilumab and, uniquely in the class, drives receptor-independent bronchodilation via pHSP20, producing FEV1 gains within 15 minutes through IV formulation. 
That speed could allow rademikibart to enter the acute exacerbation setting no current biologic is approved. 
 
FDA-aligned 28-day treatment-failure endpoint, which could then bridge patients into chronic maintenance where value concentrates. 
 
The two Phase 2 Seabreeze STAT studies (asthma and COPD, n = 160 each) read out in 2H26, the asthma topline in early September, as the valuation-inflection event.

StockTwits Web

Connect Biopharma Holdings Ltd

Sanofi-Aventis

Regeneron Pharmaceuticals, Inc.

Quantumup

$CNTB H.C. Wainwright 
$7 
Buy 
243.14% 
Upside 
Reiterated 
09/14/26 
 
yes that is true rerated today ?

Maj Vilić

 Buy-$7 and said -- We recently hosted a KOL discussion ahead of Connect Biopharma's upcoming Seabreeze STAT asthma and COPD readouts and came away incrementally more positive on the setup. 


 - REGN VRNA GSK AZN ABBV INSM LQDA 
H.C. Wainwright added—Most importantly, the KOL viewed treatment failure, including recurrent exacerbations and repeat acute-care utilization, as the most clinically meaningful measure of success, with approximately 30% relative reduction representing a meaningful win, ~40% a strong outcome and ~50% an especially compelling result. 
 
FEV1 remains important, but in our view the discussion reinforces that Seabreeze should be assessed primarily on whether rademikibart meaningfully reduces treatment failure over 28 days as that is the key measure physicians care about in practice. 
 
We believe this provides a favorable framework heading into the catalyst and remain positive on CNTB shares.